Shamburg News · 8-K filed Nov 10, 2026, 4:04 PM EST
Achieve Life Sciences Reports Third Quarter 2026 Results and Business Updates
ACHV · ACHIEVE LIFE SCIENCES, INC.
- Earnings
- Leadership change
- Materiality: high
On November 10, 2026, Achieve Life Sciences, Inc. (doing business as AchieveRx) reported third quarter 2026 financial results and business updates in Exhibit 99.1. The company reported a net loss of $12.1 million for the quarter and cash, cash equivalents, and marketable securities of $201.5 million as of September 30, 2026. The filing also reports two senior appointments, including Ben Halladay as Chief Financial Officer, and an NDA resubmission expected in the fourth quarter of 2026.
Source: SEC EDGAR, Form 8-K, Items 2.02, 9.01, accession 0001193125-26-455404.
Written from the filing by Shamburg Markets. Figures are as reported by the company.